This paper aims to discuss the role and the accuracy of positron emission tomography (PET) and to evaluate computed tomography (CT) contrast enhancement in diagnosing the nature of lung nodules detected by low-dose CT, performed as screening for lung cancer. When applying strict admission criteria to the test, CT contrast enhancement is feasible in 40% of nodules and gives an accurate diagnosis of benignity when enhancement is <15 HU: this occurs in only 5% of cases, but the diagnosis has to be considered certain, sparing further examination and/or follow-up. PET, performed with the most up-to-date equipment, can evaluate nodules with diameter >7 mm. The sensitivity is 87% and specificity 76%. Contrast enhancement study and PET are promising in the diagnostic work-up of lung nodules, as they reduce follow-up, the number of Fine Needle Aspiration Biopsy (FNAB), costs, radiation exposure and patients� anxiety.

Author

M Bellomi, E De Fiori, S Ferretti, C Rampinelli, C Trentin

Contact Details

Corresponding address:

Reference

ICIS Cancer Imaging Volume 4 Special Issue B
DOI: 10.1102/1470-7330.2004.0033

Date Posted

3 January 2005

Print PDF

Size

3.74 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	14 seconds
ADSL 512Kb/s (Broadband):	59 seconds
64 Kb/s (ISDN):	7 minutes 58 seconds
33.3 Kb/s (Typical Modem):	15 minutes 19 seconds

Screen PDF

Size

248.57 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	3 seconds
64 Kb/s (ISDN):	31 seconds
33.3 Kb/s (Typical Modem):	59 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.